Primary cardiac angiosarcoma: in a patient with a dacron aortic prosthesis
Nathan J Almeida1, Priscilla Hoang, Paul Biddle
1The Cardiac Center of Creighton University, Creighton University Medical Center, Omaha, Nebraska 68131, USA. nathan.almeida@cardiac.creighton.edu
Texas Heart Institute Journal
|March 23, 2011
Summary
This report details a rare primary cardiac angiosarcoma linked to a Dacron graft used for aortic dissection repair. Despite treatment options, the prognosis for this rare cancer remains poor.
Area of Science:
- Cardiovascular Pathology
- Surgical Oncology
- Medical Oncology
Background:
- Primary cardiac angiosarcomas are rare and aggressive tumors.
- Dacron prostheses are rarely associated with secondary neoplasia.
- Aortic dissection repair often involves synthetic grafts like Dacron.
Observation:
- A patient with a history of aortic dissection repair using a Dacron graft developed a primary cardiac angiosarcoma.
- The patient presented with extensive metastatic disease.
- This represents a potential, though rare, long-term complication of Dacron graft implantation.
Findings:
- This is the first reported case of primary cardiac angiosarcoma associated with a Dacron graft.
- The angiosarcoma likely arose in proximity to the Dacron prosthesis.
- Metastatic spread significantly impacts patient outcomes.
Implications:
- Highlights a rare but serious potential complication of synthetic vascular grafts.
- Suggests vigilance for neoplastic changes in patients with cardiovascular prostheses.
- Emphasizes the poor prognosis of advanced cardiac angiosarcoma, despite multimodal treatment including surgery, chemotherapy, radiotherapy, and transplantation.
